Navigation Links
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Date:1/24/2008

million. For pediatricians, amoxicillin is the most prescribed drug among all therapeutic classes. Among family physicians, amoxicillin is the twelfth most prescribed drug among all therapeutic classes.

The most commonly prescribed treatment for the management of Group A streptococcal pharyngitis is 500 milligrams of amoxicillin dosed three-times daily for a period of 10 days. With the FDA approval of MOXATAG, physicians now have available the first once-daily product in the aminopenicillin class for the treatment of pharyngitis while utilizing approximately one-half the amount of amoxicillin currently used.

About pharyngitis/tonsillitis:

Pharyngitis is a painful inflammation of the throat caused by a variety of microorganisms, both viral and bacterial. About 15 million patients annually seek relief of sore throat symptoms in the United States. The most common bacterial cause of acute pharyngitis is Streptococcus pyogenes, or Group A streptococcus, which is referred to as "strep throat." Symptoms of strep throat include fever, painful swallowing, swelling of the throat, and headache. Symptomatic strep throat can lead to complications, such as rheumatic fever, and should be treated with antibiotic therapy. Pharyngitis ranks in the top ten diagnoses made by pediatricians, family physicians, and emergency medicine specialists.

About Middlebrook Pharmaceuticals:

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a pharmaceutical company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing anti-infective drugs based on its novel biological finding that bacteria exposed to antibi
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
2. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
3. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
4. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
7. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
8. New Data Show Unacceptably Low Adult Immunization Rates and That Adults Unaware of Infectious Disease Threat
9. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
10. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Creekridge Capital, an independent, national commercial finance ... adding two new sales representatives. Sam Puma ... and Stefanie Stark joined the company as ... Creekridge with over 20 years of vendor and direct ... Puma will be responsible for identifying, implementing and growing ...
(Date:6/3/2015)... 2015 Research and Markets  ( http://www.researchandmarkets.com/research/dg23tb/global ) ... Packaging Market 2015-2019" report to their offering. ... a CAGR of 5.9% over the period 2014-2019. ... is the rise in demand for vials and ampules. ... highest growth among all the segments at a CAGR ...
(Date:6/3/2015)... , June 3, 2015  (AHIP Institute Booth 1021) ... network, will be providing a wide range of information ... during the America,s Health Insurance Plan,s (AHIP,s) 2015 ... Availity released a special ... of waste and missed opportunities." The report ...
Breaking Medicine Technology:Creekridge Capital Strengthens Sales Team 2Global Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, Gerresheimer, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 2Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 3
(Date:6/3/2015)... Loma Linda University Health and Adventist Health ... Memorial Hospital (SGMH). The SGMH board voted unanimously to ... “Loma Linda University Health has been serving the Pass ... officer, Loma Linda University Medical Center. “We are thrilled ... this community.” , Under the proposed affiliation, Loma ...
(Date:6/3/2015)... June 03, 2015 Johnson & Johnson ... $7.8 million to resolve a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ... the company allegedly used to market the antipsychotic drug. ... indicate that the Arkansas Attorney General moved to dismiss ... accord. The Risperdal settlement amounts to just a fraction ...
(Date:6/3/2015)... DC (PRWEB) June 03, 2015 The ... to announce that Maria C. Savoia, M.D., Dean of Medical ... of Medicine, will become Chair on July 1. ... Chair of the National Resident Matching Program,” said Dr. Savoia. ... reliable process for matching medical students with training programs, and ...
(Date:6/3/2015)... Baltimore, MD (PRWEB) June 03, 2015 On ... be a $13 billion industry by 2020 ( click here ... and Markets), computer scientists believe Baltimore has the ... fast-growing industry in which genetic code and other biological data ... and cure disease. “Baltimore contains all the elements of ...
(Date:6/3/2015)... Newark, New Jersey (PRWEB) June 03, 2015 ... chosen by Diversity MBA Magazine as one of the nation’s ... ranked Horizon BCBSNJ No. 6 among its national list of ... ranked Horizon BNCBSNJ as the No. 1 Regional Company. ... been honored by Diversity MBA Magazine for its diverse workplace ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2
... $5 million expanded initiative sponsored by the National Institutes ... predict cardiovascular disease and to assess potential new treatments ... million Americans have diabetes, the seventh leading cause of ... cause of heart disease, stroke, kidney disease, blindness and ...
... coronary intervention (PCI), also known as angioplasty, exhibit ... Risk-adjusted analyses have now indicated that, in the ... predictor following PCI according to the study now ... a journal published by Wiley-Blackwell on behalf of ...
... November issue of the Journal of the American ... management of incidental findings found on body computed tomography ... is unrelated to the present illness and is discovered ... radiologists, ability to identify small or subtle findings. In ...
... Summary of a study being published online Oct. 31, 2011, in ... of women who carry mutations in a BRCA gene - but ... have an increased risk of developing breast cancer compared to relatives ... These results run counter to a previous study showing a higher ...
... , MONDAY, Oct. 31 (HealthDay News) -- Jay Cuetara arrived ... was told a critical component of the chemo cocktail that ... was unavailable. Cuetara, 49, didn,t get treatment that ... His San Francisco hospital managed to procure the drug and ...
... and the development of age-related diseases such as cancer and ... is reduced, the greater the effect. Researchers at the University ... hold the key to the ageing process. "We are ... preventing an enzyme, peroxiredoxin, from being inactivated. This enzyme is ...
Cached Medicine News:Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 2Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 3Health News:Women undergoing PCI display greater number of co-morbidities than men 2Health News:Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation 2Health News:Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation 3Health News:Obama Acts to Ease U.S. Drug Shortages 2Health News:Obama Acts to Ease U.S. Drug Shortages 3Health News:Live longer with fewer calories 2
... Weve added an elastic belt to help ... The Special Procedure Apron features all around protection ... over-the-shoulder snaplock makes wearing and removing a breeze. ... new Back Belts - they reduce pressure on ...
... a 2 adjustable belt buckle. You adjust once ... Apron off your shoulders. And now theres our ... female anatomy. ,For additional back support try one ... pressure on the vertebrae and help lift the ...
StelKast's Proven™ Knee System is a long term high quality solution based on a clinically proven and successful design....
... The TC-PLUS Solution tricompartmental total knee prosthesis ... knee arthroplasty. State-of-the-art design and manufacturing technologies ... optimum biomechanical function as well as a ... tibial insert to keep wear to a ...
Medicine Products: